Safety and Tolerability of Thrombin Inhibition in Scleroderma‐Associated Interstitial Lung Disease

OBJECTIVE: Interstitial lung disease (ILD) is a frequent complication of systemic sclerosis (SSc) (scleroderma) and the leading cause of scleroderma‐related deaths. There exists an unmet need for a new drug therapy for ILD‐complicated SSc. Substantial evidence supports an important role for thrombin...

全面介紹

Na minha lista:
書目詳細資料
發表在:ACR Open Rheumatol
Main Authors: Silver, R. M., Wilson, D. A., Akter, T., Atanelishvili, I., Huggins, J. T., Kajdasz, K., Highland, K. B., Nietert, P. J., Bogatkevich, G. S.
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2019
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858036/
https://ncbi.nlm.nih.gov/pubmed/31777820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr2.11049
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍